Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN2A | Q99250 | 5/20 | 0.77 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.77 |
| ▸ | PTPN11 | Q06124 | 12/20 | 0.53 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.51 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.40 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.37 |
| ▸ | SCN10A | Q9Y5Y9 | 3/20 | 0.37 |
| ▸ | SCN1A | P35498 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sipatrigine SCHEMBL135888 | 0.87 | SCN2A (1.00) | SCN2AKCNK2PTPN11 | |
| Sipatrigine SCHEMBL29421474 | 0.87 | SCN2A (1.00) | SCN2AKCNK2PTPN11 | |
| SCHEMBL7272688 | 0.84 | SCN2A (0.77) | SCN2AKCNK2PTPN11ALKSCN9A | |
| SCHEMBL8576787 | 0.82 | SCN2A (0.74) | SCN2AKCNK2PTPN11 | |
| SCHEMBL134958 | 0.82 | SCN2A (0.74) | SCN2AKCNK2PTPN11SCN9A | |
| SCHEMBL132945 | 0.82 | SCN2A (0.77) | SCN2AKCNK2PTPN11SCN9A | |
| SCHEMBL7280623 | 0.81 | SCN2A (0.73) | SCN2AKCNK2PTPN11ALKSCN9A | |
| SCHEMBL7286933 | 0.81 | SCN2A (0.71) | SCN2AKCNK2PTPN11ALKSCN9A | |
| Sipatrigine SCHEMBL5069235 | 0.80 | SCN2A (0.85) | SCN2AKCNK2PTPN11SCN9ASCN3A | |
| SCHEMBL7278654 | 0.80 | SCN2A (0.74) | SCN2AKCNK2PTPN11ALKSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0679645-A1 | Pharmacologically active CNS pyridmidin compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-11-02 | — | — | EP | claimed |
| EP-0459819-A2 | Pharmacologically active CNS compound | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-12-04 | — | — | EP | claimed |
| EP-0679645-A1 | Pharmacologically active CNS pyridmidin compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-11-02 | — | — | EP | disclosed |
| EP-0459819-A2 | Pharmacologically active CNS compound | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-12-04 | — | — | EP | disclosed |